CN103705846A - Traditional Chinese medicine preparation for treating ovarian cyst - Google Patents
Traditional Chinese medicine preparation for treating ovarian cyst Download PDFInfo
- Publication number
- CN103705846A CN103705846A CN201310725328.5A CN201310725328A CN103705846A CN 103705846 A CN103705846 A CN 103705846A CN 201310725328 A CN201310725328 A CN 201310725328A CN 103705846 A CN103705846 A CN 103705846A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine preparation
- rhizoma
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 39
- 208000010433 Ovarian Cysts Diseases 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 10
- 241000756943 Codonopsis Species 0.000 claims description 9
- 235000005903 Dioscorea Nutrition 0.000 claims description 6
- 235000000504 Dioscorea villosa Nutrition 0.000 claims description 6
- 241000545442 Radix Species 0.000 claims description 6
- 235000004879 dioscorea Nutrition 0.000 claims description 6
- 240000005760 Dioscorea villosa Species 0.000 claims 1
- 230000001737 promoting Effects 0.000 abstract description 12
- 230000017531 blood circulation Effects 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 9
- 210000004369 Blood Anatomy 0.000 abstract description 5
- 239000008280 blood Substances 0.000 abstract description 5
- 229940079593 drugs Drugs 0.000 abstract description 5
- 230000004087 circulation Effects 0.000 abstract description 4
- 230000000144 pharmacologic effect Effects 0.000 abstract description 4
- 210000004185 Liver Anatomy 0.000 abstract description 3
- 231100000486 side effect Toxicity 0.000 abstract description 3
- 238000010792 warming Methods 0.000 abstract description 3
- 230000004069 differentiation Effects 0.000 abstract description 2
- 241001061264 Astragalus Species 0.000 abstract 1
- 244000192528 Chrysanthemum parthenium Species 0.000 abstract 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 abstract 1
- 240000004499 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 235000014375 Curcuma Nutrition 0.000 abstract 1
- 240000002123 Curcuma aromatica Species 0.000 abstract 1
- 240000009138 Curcuma zedoaria Species 0.000 abstract 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 abstract 1
- 241001226187 Cyrtomium fortunei Species 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 240000005389 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000010696 Leonuro Nutrition 0.000 abstract 1
- 240000008259 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 208000004880 Polyuria Diseases 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 abstract 1
- 230000035619 diuresis Effects 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 235000014063 licorice root Nutrition 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 230000025627 positive regulation of urine volume Effects 0.000 abstract 1
- 201000010874 syndrome Diseases 0.000 abstract 1
- 230000002195 synergetic Effects 0.000 abstract 1
- 210000000456 talus bone Anatomy 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 235000019509 white turmeric Nutrition 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 9
- 241000234273 Dioscorea Species 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 210000000952 Spleen Anatomy 0.000 description 5
- 238000009825 accumulation Methods 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 230000001717 pathogenic Effects 0.000 description 4
- 244000052769 pathogens Species 0.000 description 4
- 230000001225 therapeutic Effects 0.000 description 4
- 239000009636 Huang Qi Substances 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 210000001015 Abdomen Anatomy 0.000 description 2
- 206010011732 Cyst Diseases 0.000 description 2
- 229940023488 Pill Drugs 0.000 description 2
- 231100000614 Poison Toxicity 0.000 description 2
- 230000003266 anti-allergic Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000003821 menstrual periods Effects 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010025482 Malaise Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 210000004291 Uterus Anatomy 0.000 description 1
- 206010047461 Viral infection Diseases 0.000 description 1
- 208000001756 Virus Disease Diseases 0.000 description 1
- 230000003110 anti-inflammatory Effects 0.000 description 1
- 230000002155 anti-virotic Effects 0.000 description 1
- 230000003115 biocidal Effects 0.000 description 1
- 230000003750 conditioning Effects 0.000 description 1
- 230000003467 diminishing Effects 0.000 description 1
- 201000009910 diseases by infectious agent Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000008956 guizhi-fuling Substances 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 201000006518 pelvic inflammatory disease Diseases 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000017613 viral reproduction Effects 0.000 description 1
Abstract
The invention discloses a traditional Chinese medicine preparation for treating ovarian cyst. The traditional Chinese medicine preparation for treating ovarian cyst is prepared from the following raw medicines: astragalus, codonopsis pilosula, Chinese yam, rhizoma smilacis glabrae, red paeony root, cyrtomium fortunei, curcuma zedoary, pericarpium arecae, rhizoma sparganii, poria cocos, cassia twig, motherwort, dried tangerine or orange peel, fructus aurantii and liquorice. The medicines are combined with one another, so that the synergistic effect is generated among the effects of the medicines, and the effects of soothing the liver, inducing diuresis, promoting blood circulation to remove blood stasis, warming meridians and promoting coronary circulation, nourishing qi and promoting circulation and promoting blood circulation and eliminating stagnation are achieved. Therefore, the traditional Chinese medicine preparation for treating ovarian cyst accords with the principle of syndrome differentiation and treatment in traditional Chinese medicine and is supported by modern pharmacological research, so that the curative effect is obvious. Moreover, the traditional Chinese medicine preparation does not have a toxic or side effect, is stable in long-term curative effect and convenient to take and is worthy of popularization and application.
Description
Technical field
The invention belongs to Chinese medicine technical field, be specifically related to a kind of Chinese medicine preparation for the treatment of ovarian cyst.
Background technology
Ovarian cyst is gynecological clinic common disease, accounts for 90% of ovarian tumor.Be common in women at fertile age, sickness rate accounts for 5% of women at fertile age, it is optimum that ovarian cyst mostly is, early stage many no conscious symptons, but the increase gradually along with cyst, clinically there is the diseases such as irregular, dysmenorrhea of menstruation menstrual period, cycle, affect women's healthy and fertility, caused very big misery to patient's body and mind.It is closely related that modern medicine thinks that primary disease occurs with pelvic inflammatory disease outbreak repeatedly, viral infection, endocrine disturbance etc.The problems such as for the treatment of primary disease, doctor trained in Western medicine often adopts under antibiotic infection, operative treatment or B ultrasonic localised puncture to extract capsule liquid, but has easily recurrence, and Western medicine side effect is larger, and Complications after surgical treatment is many.Chinese traditional treatment primary disease has accumulated rich experiences, satisfactory effect.The Chinese patent medicine that has on the market at present some treatment primary disease, but onset is slow mostly, uncertain therapeutic efficacy is cut and expensive.Therefore, find a kind of safe and effective, taking convenience, low-cost Chinese medicine preparation become ovarian cyst patient in the urgent need to.
Summary of the invention
For the etiology and pathology of ovarian cyst, anti-inflammation, antiallergic action, raising immunity of organisms, improve microcirculation and promote that histiocyte reparation is the pharmacological basis for the treatment of by Chinese herbs ovarian cyst.The inventor, through long-term clinical practice, research repeatedly, has found the Chinese medicine preparation (capsule ball disappears) of the treatment ovarian cyst of better efficacy finally.
Therefore, the object of the invention is to provide that a kind of side effect is little, treating both the principal and secondary aspects of a disease, can more effectively treat the Chinese medicine preparation of ovarian cyst.
For achieving the above object, the technical scheme that the present invention takes is that the Chinese medicine preparation of described treatment ovarian cyst is to be made by the former medicine of following weight portion: 20～40 parts of the Radixs Astragali, 10～20 parts of Radix Codonopsis, 10～30 parts of Rhizoma Dioscoreaes, 20～40 parts of Rhizoma Smilacis Glabraes, 10～20 parts of Radix Paeoniae Rubra, 10～20 parts of Rhizoma Osmundae, 10～20 parts of Rhizoma Curcumae, 10～20 parts of Pericarpium Arecae, 5～15 parts of Rhizoma Sparganii, 10～20 parts, Poria, 5～15 parts of Ramulus Cinnamomi, 10～30 parts of Herba Leonuris, 10～20 parts of Pericarpium Citri Reticulataes, 10～20 parts of Fructus Aurantiis, 3～9 parts, Radix Glycyrrhizae.
The medicament selection Radix Astragali of the present invention, Radix Codonopsis, Rhizoma Dioscoreae, Rhizoma Smilacis Glabrae, Radix Paeoniae Rubra, Rhizoma Osmundae, Rhizoma Curcumae, Pericarpium Arecae, Rhizoma Sparganii, Poria, Ramulus Cinnamomi, Herba Leonuri, Pericarpium Citri Reticulatae, Fructus Aurantii, Radix Glycyrrhizae combine, make each efficacy of drugs produce synergism these drug regimens, thereby be effectively total to long memorial liver, dampness removing, removing toxic substances, blood circulation promoting and blood stasis dispelling, warming the meridian and promoting blood circulation, the effect of promote the circulation of qi and water, blood circulation promoting and dispersing pathogen accumulation.
Motherland's medical science is thought, ovarian cyst genus " mass in the abdomen ", " lump in the abdomen ", " gathering " category.How, because women ignores conditioning in menstrual period or puerperal, in the heresy because of internal injury caused by excess of seven emotions or six climate exopathogens, invade, visceral dysfunction, causes in turbid damp phlegm retention rawly, and stagnation of blood stasis vessels of the uterus, accumulates and with the passing of time form cyst.Therefore primary disease pathogenesis core is: stagnation of liver-QI with deficiency of the spleen, phlegm and blood stasis.Treatment should invigorating the spleen and relieving depression of liver-QI, dampness removing reduces phlegm, the method for blood circulation promoting and dispersing pathogen accumulation.The Chinese medicine preparation for the treatment of ovarian cyst of the present invention (calling the capsule ball that disappears in the following text) is reused the Radix Astragali, Radix Codonopsis, Rhizoma Dioscoreae spleen invigorating, Pericarpium Citri Reticulatae, Fructus Aurantii is soothing the liver, Poria, Pericarpium Arecae dampness removing, Rhizoma Smilacis Glabrae, Rhizoma Osmundae removing toxic substances, Rhizoma Sparganii, Rhizoma Curcumae, Radix Paeoniae Rubra, Herba Leonuri blood circulation promoting and blood stasis dispelling, Ramulus Cinnamomi warming the meridian and promoting blood circulation, promote the circulation of qi and water, Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription.Gather altogether that invigorating the spleen and relieving depression of liver-QI, dampness removing reduce phlegm, the effect of blood circulation promoting and dispersing pathogen accumulation.Modern pharmacological research shows: the Radix Astragali, Radix Codonopsis, Rhizoma Dioscoreae, Poria can improve immunity of organisms; Rhizoma Smilacis Glabrae, Pericarpium Arecae, Rhizoma Sparganii, Rhizoma Curcumae, Rhizoma Osmundae etc. all have inhibiting bacteria and diminishing inflammation, antivirus action; Pericarpium Citri Reticulatae, Fructus Aurantii, Radix Glycyrrhizae antiallergic action; Blood-activating and stasis-removing can be improved microcirculation, reduce vascular permeability.
Visible, the Chinese medicine preparation for the treatment of ovarian cyst of the present invention had both met the principle of motherland's medical science determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs, had again modern pharmacological research support, therefore evident in efficacy; And have no side effect, late result is stable, and taking convenience, is worthy of popularization.
The specific embodiment
The Chinese medicine preparation for the treatment of ovarian cyst of the present invention is to be made by the former medicine of following weight portion: 20～40 parts of the Radixs Astragali, 10～20 parts of Radix Codonopsis, 10～30 parts of Rhizoma Dioscoreaes, 20～40 parts of Rhizoma Smilacis Glabraes, 10～20 parts of Radix Paeoniae Rubra, 10～20 parts of Rhizoma Osmundae, 10～20 parts of Rhizoma Curcumae, 10～20 parts of Pericarpium Arecae, 5～15 parts of Rhizoma Sparganii, 10～20 parts, Poria, 5～15 parts of Ramulus Cinnamomi, 10～30 parts of Herba Leonuris, 10～20 parts of Pericarpium Citri Reticulataes, 10～20 parts of Fructus Aurantiis, 3～9 parts, Radix Glycyrrhizae.
Medicine-feeding is fine flour altogether, develop as the watered pill, mono-bag of 24g, 2 times on the one, one time 1 bag.14 days courses for the treatment of.
Embodiment mono-:
The Chinese medicine preparation for the treatment of ovarian cyst of the present invention is to be made by the former medicine of following weight portion: 20 parts of the Radixs Astragali, 10 parts of Radix Codonopsis, 10 parts of Rhizoma Dioscoreaes, 20 parts of Rhizoma Smilacis Glabraes, 10 parts of Radix Paeoniae Rubra, 10 parts of Rhizoma Osmundae, 10 parts of Rhizoma Curcumae, 10 parts of Pericarpium Arecae, 5 parts of Rhizoma Sparganii, 10 parts, Poria, 5 parts of Ramulus Cinnamomi, 10 parts of Herba Leonuris, 10 parts of Pericarpium Citri Reticulataes, 10 parts of Fructus Aurantiis, 3 parts, Radix Glycyrrhizae.
Embodiment bis-:
The Chinese medicine preparation for the treatment of ovarian cyst of the present invention is to be made by the former medicine of following weight portion: 30 parts of the Radixs Astragali, 15 parts of Radix Codonopsis, 20 parts of Rhizoma Dioscoreaes, 30 parts of Rhizoma Smilacis Glabraes, 5 parts of Radix Paeoniae Rubra, 15 parts of Rhizoma Osmundae, 15 parts of Rhizoma Curcumae, 15 parts of Pericarpium Arecae, 10 parts of Rhizoma Sparganii, 15 parts, Poria, 10 parts of Ramulus Cinnamomi, 20 parts of Herba Leonuris, 15 parts of Pericarpium Citri Reticulataes, 15 parts of Fructus Aurantiis, 6 parts, Radix Glycyrrhizae.
Embodiment tri-:
The Chinese medicine preparation for the treatment of ovarian cyst of the present invention is to be made by the former medicine of following weight portion: 40 parts of the Radixs Astragali, 20 parts of Radix Codonopsis, 30 parts of Rhizoma Dioscoreaes, 40 parts of Rhizoma Smilacis Glabraes, 20 parts of Radix Paeoniae Rubra, 20 parts of Rhizoma Osmundae, 20 parts of Rhizoma Curcumae, 20 parts of Pericarpium Arecae, 15 parts of Rhizoma Sparganii, 20 parts, Poria, 15 parts of Ramulus Cinnamomi, 30 parts of Herba Leonuris, 20 parts of Pericarpium Citri Reticulataes, 20 parts of Fructus Aurantiis, 9 parts, Radix Glycyrrhizae.
clinical observation material
(1) invention medicine major function and therapeutic domain
1, major function:
Invigorating the spleen and relieving depression of liver-QI, dampness removing reduce phlegm, blood circulation promoting and dispersing pathogen accumulation.
2, therapeutic domain:
Be applicable to ovarian cyst.
(2) clinical observation of medicine of the present invention
Treatment group Drug therapy of the present invention, matched group Guizhi Fuling Pills in Treating.Therapeutic outcome: in treatment group 151 examples, recovery from illness 45 examples, account for 29.8%; Effective 32 examples, account for 21.2%; Effective 60 examples, account for 39.7%; Invalid 14 examples, account for 9.3%; Total effective rate 90.7%.29 examples of fully recovering in matched group 143 examples, account for 20.3%; Effective 36 examples, account for 25.2%; Effective 36 examples, account for 25.2%; Invalid 42 examples, account for 29.3%; Total effective rate 70.7%.Two groups of total effective rates compare P < 0.01
Table 1 liang group curative effect comparison
The capsule ball group that disappears as can be seen from Table 1 curative effect is obviously better than Ramulus Cinnamomi Poria pill group (p < 0.01).
Claims (1)
1. treat a Chinese medicine preparation for ovarian cyst, the Chinese medicine preparation that it is characterized in that described treatment ovarian cyst is to be made by the former medicine of following weight portion: 20～40 parts of the Radixs Astragali, 10～20 parts of Radix Codonopsis, 10～30 parts of Rhizoma Dioscoreaes, 20～40 parts of Rhizoma Smilacis Glabraes, 10～20 parts of Radix Paeoniae Rubra, 10～20 parts of Rhizoma Osmundae, 10～20 parts of Rhizoma Curcumae, 10～20 parts of Pericarpium Arecae, 5～15 parts of Rhizoma Sparganii, 10～20 parts, Poria, 5～15 parts of Ramulus Cinnamomi, 10～30 parts of Herba Leonuris, 10～20 parts of Pericarpium Citri Reticulataes, 10～20 parts of Fructus Aurantiis, 3～9 parts, Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310725328.5A CN103705846B (en) | 2013-12-25 | 2013-12-25 | The Chinese medicine preparation for the treatment of ovarian cyst |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310725328.5A CN103705846B (en) | 2013-12-25 | 2013-12-25 | The Chinese medicine preparation for the treatment of ovarian cyst |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103705846A true CN103705846A (en) | 2014-04-09 |
| CN103705846B CN103705846B (en) | 2016-02-03 |
Family
ID=50399433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310725328.5A Expired - Fee Related CN103705846B (en) | 2013-12-25 | 2013-12-25 | The Chinese medicine preparation for the treatment of ovarian cyst |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103705846B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104383181A (en) * | 2014-11-12 | 2015-03-04 | 安顺市西秀区钰霖种养殖农民专业合作社 | Pharmaceutical composition containing paeonia lactiflora and preparation method of pharmaceutical composition |
| CN104587399A (en) * | 2015-01-23 | 2015-05-06 | 青岛市中心医院 | Traditional Chinese medicine for treating ovarian cyst |
| CN104815163A (en) * | 2015-04-17 | 2015-08-05 | 王�琦 | Traditional Chinese medicine prescription for treating ovarian cyst |
-
2013
- 2013-12-25 CN CN201310725328.5A patent/CN103705846B/en not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| 刘军莲等: "多囊卵巢综合征经验方中医辨证概述", 《辽宁中医杂志》, vol. 40, no. 3, 31 March 2013 (2013-03-31) * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104383181A (en) * | 2014-11-12 | 2015-03-04 | 安顺市西秀区钰霖种养殖农民专业合作社 | Pharmaceutical composition containing paeonia lactiflora and preparation method of pharmaceutical composition |
| CN104587399A (en) * | 2015-01-23 | 2015-05-06 | 青岛市中心医院 | Traditional Chinese medicine for treating ovarian cyst |
| CN104815163A (en) * | 2015-04-17 | 2015-08-05 | 王�琦 | Traditional Chinese medicine prescription for treating ovarian cyst |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103705846B (en) | 2016-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102178901B (en) | Medicament for treating uterus cancer | |
| CN102940853B (en) | Navel paste for treating mammary gland hyperplasia diseases | |
| CN103316174B (en) | Traditional Chinese medicinal composition for treating acute cholecystitis and preparation method thereof | |
| CN104587442A (en) | Foot bath traditional Chinese medicine composition for treating wind-cold-dampness arthralgia and application of foot bath traditional Chinese medicine composition | |
| CN101711848B (en) | Chinese medicinal composition capable of adjunctively treating tumour | |
| CN103463357A (en) | Medicinal liquor capable of warming and invigorating kidney yang and preparing method thereof | |
| CN103705846B (en) | The Chinese medicine preparation for the treatment of ovarian cyst | |
| CN104491220A (en) | Traditional Chinese medicine composition for treating herpes zoster | |
| CN103845429A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN103341088B (en) | Medicine for treating blood sugar type fatty liver | |
| CN104257883A (en) | Traditional Chinese medicine composition for treating leucopenia after chemotherapy | |
| CN104107393A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis | |
| CN101491612B (en) | Medicine for treating mammary hyperplasia and early breast cancer | |
| CN102349957A (en) | Traditional Chinese medicine composition for treating prurigo | |
| CN102743686B (en) | The scorching clearing capsule of a kind of basin | |
| CN102205067B (en) | Traditional Chinese medicine composition for treating chronic urticaria | |
| CN1517115A (en) | Chinese patent drug-Fuyan capsdule for treating chronic pelvic inflammation | |
| CN103800664A (en) | Traditional Chinese medicine composition for treating menopausal syndrome | |
| CN103341122A (en) | Traditional Chinese medicine composition for treating gallstone | |
| CN102670878B (en) | Traditional Chinese medicine decoction for treating acute mastitis | |
| CN101972306B (en) | Chinese medicinal capsule for treating chronic pelvic inflammatory disease | |
| CN102091271A (en) | Medicine for treating hyperplasia of mammary glands and preparation method thereof | |
| CN103356965A (en) | Drug for curing rheumatoid arthritis | |
| CN102764325A (en) | Chinese medicinal composition for dispelling rheumatism and relieving pain | |
| CN103285259A (en) | Traditional Chinese medicine composition for treating hyperlipidemia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB03 | Change of inventor or designer information |
Inventor after: Pang Jingsan Inventor after: Li Gaifei Inventor after: Zhang Guifang Inventor after: Zhao Zengqiang Inventor after: He Yang Inventor after: Ma Jieyu Inventor after: Li Menghua Inventor before: Pang Jingsan Inventor before: Xiao Yuehong Inventor before: Zhang Guifang Inventor before: Zhao Zengqiang Inventor before: He Yang Inventor before: Liu Hongbo Inventor before: Li Menghua |
|
| COR | Change of bibliographic data | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160203 Termination date: 20161225 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |